Merus NV gained accelerated U.S. FDA approval of Bizengri (zenocutuzumab) as the first and only targeted therapy indicated for NRG1-positive pancreatic adenocarcinoma and non-small-cell lung cancer ...
Baxter International (NYSE:BAX) said it has re-started all of its peritoneal dialysis solutions manufacturing lines at its ...